Company Update1 Min Read InvestyWise NewsonNovember 3, 2025 Alkem Laboratories Alkem Foundation & IIT Bombay Partner for Research Center Alkem Foundation and IIT Bombay are collaborating to establish a research center for immuno-therapeutics and regenerative medicines. The Alkem…
Company Update1 Min Read InvestyWise NewsonNovember 3, 2025 Ambuja Cements Confirmation of No Deviation in Preferential Issue Proceeds Ambuja Cements confirms no deviations or variations in the use of proceeds from its preferential issue of equity shares for the quarter ended…
Company Update2 Min Read InvestyWise NewsonNovember 3, 2025 Ambuja Cements FY’26 Target Capacity Increased to 155 MTPA Ambuja Cements has announced an increase in its FY’28 target capacity to 155 MTPA, up from the previous 140 MTPA. This will be achieved…
Company Update2 Min Read InvestyWise NewsonNovember 3, 2025 Ambuja Cements Q2 FY’26 Revenue Soars, Capacity Expansion Underway Ambuja Cements reported a strong Q2 FY’26 with revenue at ₹9,174 Cr, up 21% YoY. EBITDA reached ₹1,060/PMT. The company is increasing…
Corporate Action1 Min Read InvestyWise NewsonNovember 3, 2025 Ajanta Pharma Record Date Set for Interim Dividend Ajanta Pharma has announced November 10, 2025, as the record date for determining shareholders eligible to receive the company’s first…
Corporate Action2 Min Read InvestyWise NewsonNovember 3, 2025 Ajanta Pharma PAT Up 20% in Q2 FY26, Interim Dividend Declared Ajanta Pharma announced a 20% increase in Profit After Tax (PAT) for Q2 FY26. The company’s revenue from operations rose by 14% to…
Company Update2 Min Read InvestyWise NewsonNovember 3, 2025 Ambuja Cements Achieves Robust Q2 FY26 Performance, PAT Up 364% Ambuja Cements reported a strong Q2 FY26 performance, with PAT at Rs. 2,302 Cr, up 364% YoY. The company achieved its highest ever quarterly…
Company Results2 Min Read InvestyWise NewsonNovember 3, 2025 Ajanta Pharma Q2 FY26 Profit After Tax Up by 20% Ajanta Pharma announced a 20% increase in Profit After Tax (PAT) for Q2 FY26. The company reported a revenue increase of 14%, reaching ₹1,354…
Company Update1 Min Read InvestyWise NewsonNovember 3, 2025 PCBL Chemical Kaushik Roy Resigns as Managing Director, Nilesh Koul Appointed PCBL Chemical has announced that Kaushik Roy has resigned as Managing Director, effective November 3, 2025, due to personal reasons. The Board…
Board Meeting1 Min Read InvestyWise NewsonNovember 3, 2025 Ajanta Pharma Profit After Tax Up 20% in Q2 FY26 Ajanta Pharma reported a 20% increase in Profit After Tax (PAT) for Q2 FY26, reaching ₹260 cr. Revenue from operations grew by 14% to ₹1,354…